The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain

Neuropharmacology

Volumn 38, Issue 4, 1999, Pages 597-603

  Pilc, Andrzej ^a   Branski, Piotr ^a   Palucha, Agnieszka ^a   Aronowski, Jaroslaw ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Antidepressant drugs; Calcium calmodulin dependent protein kinase (CaM KII); Electroconvulsive shocks; Hippocampus; Imipramine

Indexed keywords

IMIPRAMINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; ELECTROSHOCK; HIPPOCAMPUS; IMIPRAMINE; IMMUNOBLOTTING; MALE; RATS; RATS, WISTAR;

EID: 0032984868     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00211-1     Document Type: Article

References (36)

1. 2+/calmodulin-dependent protein kinase II: potential role in neuronal damage. J. Neurochem. 58:1992;1743-1753.
2. 2+/calmodulin-dependent protein kinase II in postsynaptic densities after reversible cerebral ischemia in rats. Brain Res. 709:1996;103-110.
3. Bronstein J.M., Wasterlain C.G., Bok D., Lasher R., Farber D.B. Localization of retinal calmodulin kinase. Exp. Eye Res. 47:1988;391-402.
4. Bunney W.E. Jr., Davis J.M. Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiatry. 13:1965;483-494.
5. 2+/calmodulin- as well as cAMP-dependent protein kinase. Proceed. Nat. Acad. Sci. USA. 88:1991;5061-5065.
6. Duman R.S., Nibuya M., Vaidya V.A. A role for CREB in antidepressant action. Skolnick P Antidepressants New Pharmacological Strategies. 1997;173-194 Humana Press, Towota, New Jersey.
7. 2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61:1992;559-601.
8. Hartwig J.H., Thelen M., Rosen A., Janmey P.A., Nairn A.C., Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature. 356:1992;618-622.
9. 2+/calmodulin-dependent protein kinase II in the crude synaptosomal fraction of the vulnerable hippocampus following hypoglycemia. J. Neurochem. 64:1995;1361-1369.
10. Kelly P.T., Yip R.K., Shields S.M., Hay M. Calmodulin-dependent protein phosphorylation in synaptic junctions. J. Neurochem. 45:1985;1620-1634.
11. Kennedy M.B. The postsynaptic density. Curr. Opin. Neurobiol. 3:1993;732-737.
12. Lapin T.P., Oxenkrug K.F. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet. 1:1969;132-136.
13. Llinas R., McGuinness T.L., Leonard C.S., Sugimori M., Greengard P. Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse. Proceed. Nat. Acad. Sci. USA. 82:1985;3035-3039.
14. Lloyd K.G., Thuret F., Pilc A. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J. Pharmacol. Exp. Ther. 235:1985;191-199.
15. Mann C.D., Vu T.B., Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol. 115:1995;595-600.
16. Mogilnicka E., Czyrak A., Maj J. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur. J. Pharmacol. 138:1987;413-416.
17. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53:1989;1644-1647.
18. Nichols R.A., Sihra T.S., Czernik A.J., Nairn A.C., Greengard P. Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature. 43:1990;647-651.
19. 2+/calmodulin-dependent protein kinase II alpha and beta isoforms in some structures of the rat forebrain. Brain Res. 659:1994;179-193.
20. Perez J., Tinelli D., Brunello N., Racagni G. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur. J. Pharmacol. 172:1989;305-316.
21. Pilc A., Vetulani J. Depression by chronic electroconvulsive treatment of clonidine hypotherma and clonidine binding to rat cortical membranes. Eur. J. Pharmacol. 80:1982;109-113.
22. 2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol. Pharmacol. 48:1995;623-629.
23. Popoli M., Venegoni A., Vocaturo C., Buffa L., Perez J.P., Smeraldi E., Racagni G. Long term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus. Mol. Pharmacol. 51:1997;19-26.
24. Pucilowski O. Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology (Berl). 109:1992;12-29.
25. Racagni G., Brunello N., Tinelli D., Perez J. New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system. Pharmacopsychiatry. 25:1992;51-55.
26. Santella L., Carafoli E. Calcium signaling in the cell nucleus. FASEB J. 11:1997;1091-1109.
27. Schildkraut J.J. The catecholamine hypothesis of affective disorder: a review of supporting evidence. Am. J. Psychiatry. 122:1965;1032-1039.
28. Schwaninger M., Schofl C., Blume R., Rossig L., Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47:1995;1112-1118.
29. 2+/calmodulin-dependent protein kinase II following spinal cord ischemia. J. Neurochem. 61:1993;738-747.
30. Sherman A.D., Allers G.L. Relationship between regional distribution of imipramine and its effect on learned helplessness in the rat. Neuropharmacology. 19:1980;159-162.
31. Skolnick P., Layer R.T., Popik P., Nowak G., Paul I.A., Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29:1996;23-26.
32. Strack S., Choi S., Lovinger D.M., Colbran R.J. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J. Biol. Chem. 272:1995;13467-13470.
33. 2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity (1994). Genes Dev. 8:1994;2527-2539.
34. Taft W.C., Tennes-Rees K.A., Blair R.E., Clifton G.L., DeLorenzo R.J. Cerebral ischemia decreases endogenous calcium-dependent protein phosphorylation in gerbil brain. Brain Res. 447:1988;159-163.
35. Vetulani J., Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature. 257:1975;495-496.
36. Walaas S.I., Gorelick F.S., Greemgard P. Presence of calcium/calmodulin-dependent protein kinase II in nervs terminals of rat brain. Synapse. 3:1989;356-362.